logo-loader

FSD Pharma CEO addresses upcoming shareholder meeting, forms license agreement with Innovet Italia

Published: 14:47 18 Mar 2021 EDT

FSD Pharma Inc (NASDAQ:HUGE) (CSE:HUGE) (FRA:0K9A) CEO Raza Bokhari talks to Proactive about the group's upcoming shareholder meeting on May 14, intended to address shareholder concerns.

What's more, Bokhari says the company has formed a license agreement with Innovet Italia SRL to develop FDA-approved veterinary drugs for the treatment of gastrointestinal diseases in dogs and cats.

Ramp Metals Launches Drilling Program in Pursuit of High-Grade Nickel in...

Ramp Metals CEO Jordan Black joined Steve Darling from Proactive to introduce the company to the public domain and share exciting developments in the mining industry. With a background as a geotechnical engineer and experience in venture capital, including a notable role in taking GoldSpot...

42 minutes ago